Salicylic Acid: Where the Cosmetic and Drug Line Sits in Canada

Salicylic acid is one of those ingredients that lives comfortably in cosmetics right up until it doesn't, and the line isn't always obvious from the ingredient itself. It's the concentration and the claim sitting around it that decide whether you're filing a Cosmetic Notification Form or looking at an entirely different regulatory pathway.

The basics

Salicylic acid's INCI name is, conveniently, Salicylic Acid. Its CAS number is 69-72-7. It's a beta hydroxy acid used widely as an exfoliant, and it shows up in cleansers, toners, body washes, and spot treatments across the market.

INCI name	CAS number	Typical function	Regulatory note
Salicylic Acid	69-72-7	Exfoliant, keratolytic	Concentration and claim determine cosmetic vs drug status

Where cosmetic use ends

As a general exfoliating ingredient, salicylic acid at cosmetic-typical concentrations, used with a cosmetic claim like smoothing texture or supporting a clearer-looking complexion, sits comfortably in cosmetic territory and goes through the standard CNF process like any other ingredient. It gets checked against the Cosmetic Ingredient Hotlist for any applicable restriction, mapped to its INCI name and CAS number, and notified within 10 days of first sale.

Where this shifts is when the concentration climbs and the claim shifts alongside it, toward treating acne specifically rather than general exfoliation. Anti-acne is one of the product categories that typically moves out of cosmetic territory and into drug regulation entirely, the same way sunscreen, anti-dandruff, antiperspirant, and fluoride toothpaste are treated as drugs rather than cosmetics. The exact concentration threshold and the specific claim language that trips this line are worth confirming directly against current Health Canada guidance, since this is precisely the kind of detail that gets revisited and it's not something to guess at from a blog post, including this one.

Why the claim matters as much as the number

Two products can use the identical concentration of salicylic acid and land in different regulatory categories purely because of what the label says. A wash claiming "gently exfoliates for smoother-looking skin" reads as cosmetic. The same formula claiming "treats and prevents acne breakouts" reads as a drug claim, because it's asserting a therapeutic effect on a medical condition rather than describing a cosmetic benefit.

This is the same logic that separates true soap from cosmetic soap, just applied one step further down the line, cosmetic claim versus drug claim instead of cleansing claim versus cosmetic claim. The ingredient concentration sets a ceiling on what's plausible, but the words on your label are doing real regulatory work of their own.

What this means practically for makers

If you're formulating with salicylic acid and want to stay in cosmetic territory:

1. Keep the concentration within the range typical of cosmetic exfoliants, and if you're pushing toward the higher end of what suppliers offer, treat that as a signal to double-check where the line sits before you finalize the formula.
2. Write claims around texture, smoothing, and general skin appearance, not around treating or preventing a specific skin condition like acne.
3. Avoid language that implies a therapeutic outcome, even softened language like "helps clear breakouts," since that still reads as a drug-style claim to a regulator even if it feels like marketing softness to you.
4. If you genuinely want to make an anti-acne claim, understand you're now looking at drug regulation, not a cosmetic notification, and that's a meaningfully different and more involved process with its own evidence requirements.

A note on formulating near this line

Salicylic acid isn't unique here. Several common actives sit at this same kind of fork, cosmetic at one concentration and claim, drug-adjacent at another. The mistake to avoid is assuming the ingredient itself tells you which side you're on. It's the combination of concentration and claim, read together, that actually answers the question, and that combination is worth checking every time you adjust a formula, not just the first time you launch it.

If you're filing through Cosmetic Comply, the ingredient screening flags concentration-sensitive actives like this one against the Hotlist and known thresholds, with a confidence score and a real reviewer checking the result, which catches exactly this kind of borderline case before it becomes a filing problem rather than after.